Skip to main content

Table 4 Adverse events during airway management

From: Dexmedetomidine versus remifentanil for sedation during awake intubation using a Shikani optical stylet: a randomized, double-blinded, controlled trial

Adverse event

D

R

P-value

Hypotension

3 (8.8)

1 (2.9)

0.303

Hypertension

3 (8.8)

6 (17.6)

0.283

Tachycardia

7 (20.6)

9 (26.5)

0.567

Bradycardia

2 (5.9)

0 (0)

0.151

Hypoxia

2 (5.9)

9 (26.5)

0.021

Loosening of teeth

0 (0)

0 (0)

1.000

Injury to lip or oral mucosa

0 (0)

0 (0)

1.000

Postoperative sore throat

16 (47.1)

18 (52.9)

0.628

Hoarseness

2 (5.9)

2 (5.9)

1.000

  1. Data are given as number (proportion, %). Baseline values of systolic blood pressure (SBP), diastolic blood pressure (DBP) and peripheral oxygen saturation (SpO2) were used to define adverse events. Hypotension was defined as SBP <80 mmHg, DBP <50 mmHg or SBP decreased ≤30 % below baseline values. Hypertension was defined as SBP >180 mmHg, DBP >100 mmHg or an SBP increased ≥30 % higher than baseline values. Bradycardia was defined as HR <45 min−1 or a decrease to ≤30 % below baseline. Tachycardia was defined as HR >120 min−1 or an increased ≥30 % higher than baseline values. Hypoxia was defined as SpO2 ≤ 90 % or a decrease by ≥10 % of the baseline saturation